Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
5.21
-0.26 (-4.75%)
At close: Apr 23, 2026, 4:00 PM EDT
5.27
+0.06 (1.10%)
After-hours: Apr 23, 2026, 7:42 PM EDT
Opus Genetics Market Cap
Opus Genetics has a market cap or net worth of $370.69 million as of April 23, 2026. Its market cap has increased by 828.63% in one year.
Market Cap
370.69M
Enterprise Value
326.72M
1-Year Change
828.63%
Ranking
Category
Stock Price
$5.21
Market Cap Chart
Since November 6, 2020, Opus Genetics's market cap has increased from $21.26M to $370.69M, an increase of 1,643.38%. That is a compound annual growth rate of 68.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 389.19M | 180.76% |
| Dec 31, 2025 | 138.62M | 268.99% |
| Dec 31, 2024 | 37.57M | -44.87% |
| Dec 29, 2023 | 68.14M | -7.23% |
| Dec 30, 2022 | 73.45M | 13.82% |
| Dec 31, 2021 | 64.53M | -8.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vanda Pharmaceuticals | 403.71M |
| Niagen Bioscience | 402.84M |
| X4 Pharmaceuticals | 401.87M |
| Enanta Pharmaceuticals | 400.18M |
| Palisade Bio | 391.77M |
| Avalo Therapeutics | 387.36M |
| Immuneering | 380.81M |
| Surrozen | 379.41M |